EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Parental Somatic Mosaicism Detected During Prenatal Diagnosis

Natalie J Chandler iD, Elizabeth Scotchman iD, Fiona McKay, Vijaya Ramachandran, Lyn S Chitty iD

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.6712 ↗

At a glance

Journal article in Prenatal Diagnosis, 2025. Written by Natalie J Chandler and 4 co-authors. Institution: NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Major MEDLINE topics: Mosaicism, Noninvasive Prenatal Testing, Prenatal Diagnosis, Parents. Cited 7 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIHR Biomedical Research Centre at Great Ormond Street Hospital.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Accurate recurrence risks are essential for genomic counselling and parental reproductive choices. Historically, Sanger sequencing was used to test parental samples, which has a limited sensitivity of ∼ 10% for detecting somatic mosaicism. Next generation sequencing (NGS) methods, utilised for non‐invasive prenatal diagnosis (NIPD) and trio prenatal exome sequencing in our laboratory, have greater sensitivity. Here we review the cases of parental somatic mosaicism we have detected and discuss its impact on management.

Method

Laboratory databases from 1 January 2015 to 30 September 2022 were reviewed to identify all cases where parental somatic mosaicism was detected during NIPD and prenatal exome testing.

Results

During the development of NIPD testing, we identified 10/131 (7.6%) families with parental somatic mosaicism. In six cases where NGS detected levels between 0.37% and 8.82%, prior testing with Sanger sequencing had not detected mosaicism. In our exome sequencing cohort, we detected parental mosaicism in 4/101 (3.96%) cases. Clinical features of the condition were identified in 2/14 parents.

Conclusion

The sensitivity of the testing technique needs to be considered when counselling parents on recurrence risk. Parents need to be aware that modern approaches to prenatal diagnosis may allow identification of mosaicism, which may have implications for their own health and change recurrence risks for future pregnancies.

Subjects

MeSH terms (MEDLINE)

MosaicismNoninvasive Prenatal TestingPrenatal DiagnosisParentsHumansFemalePregnancyAdultHigh-Throughput Nucleotide SequencingGenetic TestingGenetic CounselingMaleExome Sequencing

Authors and institutions

  • NHS North Thames Genomic Laboratory Hub, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.

ORCID profiles: Natalie J Chandler, Elizabeth Scotchman, Lyn S Chitty

Funding

  • NIHR Biomedical Research Centre at Great Ormond Street Hospital

Cite

APA

Chandler, N. J., Scotchman, E., McKay, F., Ramachandran, V., & Chitty, L. S. (2025). Parental Somatic Mosaicism Detected During Prenatal Diagnosis. Prenatal Diagnosis. https://doi.org/10.1002/pd.6712

Vancouver

Chandler NJ, Scotchman E, McKay F, Ramachandran V, Chitty LS. Parental Somatic Mosaicism Detected During Prenatal Diagnosis. Prenatal Diagnosis. 2025. doi:10.1002/pd.6712

BibTeX
@article{Chandler2025,
  author = {Chandler, Natalie J and Scotchman, Elizabeth and McKay, Fiona and Ramachandran, Vijaya and Chitty, Lyn S},
  title = {Parental Somatic Mosaicism Detected During Prenatal Diagnosis},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.6712}
}
Start for free →